2023
Early Detection and Prognostic Assessment of Cutaneous Melanoma
Kashani-Sabet M, Leachman S, Stein J, Arbiser J, Berry E, Celebi J, Curiel-Lewandrowski C, Ferris L, Grant-Kels J, Grossman D, Kulkarni R, Marchetti M, Nelson K, Polsky D, Seiverling E, Swetter S, Tsao H, Verdieck-Devlaeminck A, Wei M, Bar A, Bartlett E, Bolognia J, Bowles T, B. K, Chu E, Hartman R, Hawryluk E, Jampel R, Karapetyan L, Kheterpal M, Lawson D, Leming P, Liebman T, Ming M, Sahni D, Savory S, Shaikh S, Sober A, Sondak V, Spaccarelli N, Usatine R, Venna S, Kirkwood J. Early Detection and Prognostic Assessment of Cutaneous Melanoma. JAMA Dermatology 2023, 159: 545-553. PMID: 36920356, PMCID: PMC11225588, DOI: 10.1001/jamadermatol.2023.0127.Peer-Reviewed Original ResearchConceptsRisk-stratified approachCutaneous melanomaGEP scorePrognostic assessmentGene expression profile testingMelanoma screeningEarly detectionLow-risk histologyNegative nodal statusDelphi consensus methodReflectance confocal microscopyNodal statusSentinel lymphAdvanced melanomaHistologic featuresScreening eventsScreening practicesConsensus statementConsensus recommendationsSkin lesionsDermoscopic examinationGEP testingConsensus conferenceMelanocytic skin lesionsClinical setting
2022
Features that define clinical severity of ulcerative pyoderma gangrenosum: a Delphi consensus study of experts and patients on behalf of the US Medical Dermatology Society
Pimentel M, Li M, Noe M, Latour E, Seminario-Vidal L, Greiling T, Shinkai K, Hamilton A, Alavi A, Bolognia J, Cowen E, Dominguez A, Fernandez A, Fivenson D, Huang W, Madigan L, Mauskar M, Means A, Nelson C, Patsatsi A, Pugliese D, Rojek N, Rosenbach M, Smith G, Swerlick R, Heffernan M, Mostaghimi A, Ortega-Loayza A. Features that define clinical severity of ulcerative pyoderma gangrenosum: a Delphi consensus study of experts and patients on behalf of the US Medical Dermatology Society. British Journal Of Dermatology 2022, 188: 566-568. PMID: 36746554, PMCID: PMC11110082, DOI: 10.1093/bjd/ljac137.Peer-Reviewed Original ResearchPioneers in Dermatology and Venereology: An interview with Professor Jean L. Bolognia
Bolognia J. Pioneers in Dermatology and Venereology: An interview with Professor Jean L. Bolognia. Journal Of The European Academy Of Dermatology And Venereology 2022, 36: 2264-2266. PMID: 36373810, DOI: 10.1111/jdv.18643.Commentaries, Editorials and Letters
2019
How does the International League of Dermatological Societies promote skin health for the world?
Lui H, Bolognia J, Pellacani G, Griffiths C. How does the International League of Dermatological Societies promote skin health for the world? British Journal Of Dermatology 2019, 180: 1281-1283. PMID: 31157453, DOI: 10.1111/bjd.17916.Commentaries, Editorials and Letters
2014
Global Unity in Action at the World Congress of Dermatology–Vancouver 2015
Lui H, Shapiro J, Sterry W, Bolognia J. Global Unity in Action at the World Congress of Dermatology–Vancouver 2015. Journal Of Investigative Dermatology 2014, 134: 2477-2479. PMID: 25219643, DOI: 10.1038/jid.2014.314.Commentaries, Editorials and Letters
2012
AAD/ACMS/ASDSA/ASMS 2012 Appropriate Use Criteria for Mohs Micrographic Surgery: A Report of the American Academy of Dermatology, American College of Mohs Surgery, American Society for Dermatologic Surgery Association, and the American Society for Mohs Surgery
Connolly A, Baker D, Coldiron B, Fazio M, Storrs P, Vidimos A, Zalla M, Brewer J, Begolka W, Berger R, Bigby M, Bolognia J, Brodland D, Collins S, Cronin T, Dahl M, Grant‐Kels J, Hanke C, Hruza G, James W, Lober C, McBurney E, Norton S, Roenigk R, Wheeland R, Wisco O. AAD/ACMS/ASDSA/ASMS 2012 Appropriate Use Criteria for Mohs Micrographic Surgery: A Report of the American Academy of Dermatology, American College of Mohs Surgery, American Society for Dermatologic Surgery Association, and the American Society for Mohs Surgery. Dermatologic Surgery 2012, 38: 1582-1603. PMID: 22958088, DOI: 10.1111/j.1524-4725.2012.02574.x.Peer-Reviewed Original ResearchConceptsMohs micrographic surgeryAppropriate use criteriaMohs surgeryUse criteriaMicrographic surgeryAmerican CollegeClinical scenariosAmerican SocietyAmerican AcademyUse of MMSClinical practice experienceEvidence-based medicineHealth care deliveryCalifornia Los AngelesPatient characteristicsPatient selectionClinical benefitRatings of appropriatenessAppropriateness MethodRating panelLentigo malignaAverage patientClinical experienceSurgeryPhysician's decision
2009
Signature nevi
Suh KY, Bolognia JL. Signature nevi. Journal Of The American Academy Of Dermatology 2009, 60: 508-514. PMID: 19231649, DOI: 10.1016/j.jaad.2008.10.056.Peer-Reviewed Original Research
2008
Toxic erythema of chemotherapy: A useful clinical term
Bolognia JL, Cooper DL, Glusac EJ. Toxic erythema of chemotherapy: A useful clinical term. Journal Of The American Academy Of Dermatology 2008, 59: 524-529. PMID: 18694683, DOI: 10.1016/j.jaad.2008.05.018.Commentaries, Editorials and Letters
2004
Estimating the relative risk of developing melanoma in INK4A carriers
Berwick M, Orlow I, Mahabir S, Myskowski P, Coit D, Brady M, Roy P, Song Y, Canchola R, Barz A, Halpern A, Bolognia J, Eng S, Elahi A, Begg C. Estimating the relative risk of developing melanoma in INK4A carriers. European Journal Of Cancer Prevention 2004, 13: 65-70. PMID: 15075790, DOI: 10.1097/00008469-200402000-00010.Peer-Reviewed Original ResearchMeSH KeywordsAdolescentAdultCase-Control StudiesChromatography, LiquidCyclin-Dependent Kinase Inhibitor p16FemaleGerm-Line MutationHumansMaleMelanomaMiddle AgedNeoplasms, Multiple PrimaryNevusNucleic Acid DenaturationOdds RatioPilot ProjectsPolymerase Chain ReactionPrevalenceRisk FactorsSkin NeoplasmsSurveys and QuestionnairesConceptsRisk factorsRelative riskMemorial Sloan-Kettering Cancer CenterStudy designSingle primaryCancer risk factorsMultiple primary melanomasRisk of melanomaNumber of neviPigmented lesion clinicNovel study designRare germline mutationsDermatology clinicCancer CenterNew study designsPrimary melanomaLesion clinicHigh prevalencePrimary casesPatientsMultiple primariesMelanomaGermline mutationsPilot studyFair skin
2003
Palpable Purpura in an Asthmatic Woman With Eosinophilia—Quiz Case
Pol-Rodriguez M, Crane S, Feinberg D, Glusac E, Bolognia J. Palpable Purpura in an Asthmatic Woman With Eosinophilia—Quiz Case. JAMA Dermatology 2003, 139: 803-808. PMID: 12810518, DOI: 10.1001/archderm.139.6.803-a.Peer-Reviewed Case Reports and Technical Notes
2001
The eclipse naevus: tan centre with stellate brown rim
Schaffer J, Glusac E, Bolognia J. The eclipse naevus: tan centre with stellate brown rim. British Journal Of Dermatology 2001, 145: 1023-1026. PMID: 11899128, DOI: 10.1046/j.1365-2133.2001.04538.x.Peer-Reviewed Original ResearchSpeckled lentiginous nevus--classic congenital melanocytic nevus hybrid not the result of "collision".
Schaffer J, Orlow S, Lazova R, Bolognia J. Speckled lentiginous nevus--classic congenital melanocytic nevus hybrid not the result of "collision". JAMA Dermatology 2001, 137: 1655. PMID: 11735724.Peer-Reviewed Original ResearchHumansNevus, PigmentedThe Melanocortin-1 Receptor: Red Hair and Beyond
Schaffer J, Bolognia J. The Melanocortin-1 Receptor: Red Hair and Beyond. JAMA Dermatology 2001, 137: 1477-1485. PMID: 11708951, DOI: 10.1001/archderm.137.11.1477.Peer-Reviewed Reviews, Practice Guidelines, Standards, and Consensus StatementsConceptsMelanocortin 1 receptorTransmembrane-spanning domainsG protein-coupled receptorsProtein-coupled receptorsRed hair phenotypeHuman pigmentationPigmentation phenotypesHair phenotypePheomelanin synthesisRed hairType of melaninHeterozygote effectUV-induced melanogenesisNonmelanoma skin cancerPhenotypeDecreased abilityReceptorsKey roleMelanocortin receptorsSkin cancerLociGeneticsFair skinPhysiologic variationsVariantsCerebral Mass Due to Neurocutaneous Melanosis: Eight Years Later
Schaffer J, McNiff J, Bolognia J. Cerebral Mass Due to Neurocutaneous Melanosis: Eight Years Later. Pediatric Dermatology 2001, 18: 369-377. PMID: 11737677, DOI: 10.1046/j.1525-1470.2001.01961.x.Peer-Reviewed Case Reports and Technical NotesConceptsCongenital melanocytic neviGiant congenital melanocytic nevusMagnetic resonance imagingNeurocutaneous melanosisCentral nervous system involvementExcellent long-term outcomesMedium-sized congenital melanocytic nevusMultiple satellite neviSymptomatic neurocutaneous melanosisNervous system involvementAbsence of malignancyLong-term outcomesRight temporal lobePotential surgical interventionAge 5 monthsAge 10 monthsT1-weighted imagesPerivascular collectionsSatellite neviAsymptomatic patientsEarly imagingSurgical interventionSurgical specimenSystem involvementHistologic examinationUnusual leucodermas
Bolognia J. Unusual leucodermas. Journal Of The European Academy Of Dermatology And Venereology 2001, 15: 386-387. PMID: 11763374, DOI: 10.1046/j.1468-3083.2001.00318.x.Commentaries, Editorials and LettersPointillist nevi
Huynha P, Glusac E, Bolognia J. Pointillist nevi. Journal Of The American Academy Of Dermatology 2001, 45: 397-400. PMID: 11511837, DOI: 10.1067/mjd.2001.116343.Peer-Reviewed Original ResearchConceptsMelanocytic neviHistologic featuresHistologic correlatesMelanocytic nestsJunctional melanocytic nestsAtypical melanocytic neviBenign melanocytic neviBenign melanocytic lesionsCutaneous melanomaHistologic examinationPerifollicular hypopigmentationPapillary dermisMelanocytic lesionsNeviBrown globulesUnusual patternUnusual Halo Nevi – Darkening Rather than Lightening of the Central Nevus
Huynh P, Lazova R, Bolognia J. Unusual Halo Nevi – Darkening Rather than Lightening of the Central Nevus. Dermatology 2001, 202: 324-327. PMID: 11455145, DOI: 10.1159/000051666.Peer-Reviewed Original ResearchPartial unilateral lentiginosis with ocular involvement
Schaffer J, Lazova R, Bolognia J. Partial unilateral lentiginosis with ocular involvement. Journal Of The American Academy Of Dermatology 2001, 44: 387-390. PMID: 11174424, DOI: 10.1067/mjd.2001.107968.Peer-Reviewed Case Reports and Technical NotesSpeckled lentiginous nevus: within the spectrum of congenital melanocytic nevi.
Schaffer J, Orlow S, Lazova R, Bolognia J. Speckled lentiginous nevus: within the spectrum of congenital melanocytic nevi. JAMA Dermatology 2001, 137: 172-8. PMID: 11176689.Peer-Reviewed Original ResearchConceptsCongenital melanocytic neviLentiginous nevusMelanocytic neviCongenital neviSpeckled lentiginous nevusTypes of neviHistologic featuresCongenital natureClinical appearanceBiopsy specimensHistologic examinationLesionsSame lesionNatural historyPigmented lesionsNeviMultiple reportsSubtypesBirthPattern of distributionAdditional evidencePatientsPerinuclear antineutrophilic cytoplasmic antibody-positive cutaneous polyarteritis nodosa associated with minocycline therapy for acne vulgaris
Schaffer J, Davidson D, McNiff J, Bolognia J. Perinuclear antineutrophilic cytoplasmic antibody-positive cutaneous polyarteritis nodosa associated with minocycline therapy for acne vulgaris. Journal Of The American Academy Of Dermatology 2001, 44: 198-206. PMID: 11174376, DOI: 10.1067/mjd.2001.112218.Peer-Reviewed Case Reports and Technical NotesConceptsLong-term minocycline therapyCutaneous polyarteritis nodosaAntineutrophil cytoplasmic antibodyPolyarteritis nodosaMinocycline therapyCytoplasmic antibodiesSubcutaneous nodulesAcne vulgarisPerinuclear antineutrophil cytoplasmic antibodyAntinuclear antibody panelDiscontinuation of minocyclineDrug-induced lupusUnusual side effectMedium-sized arteriesLong-term treatmentAutoimmune hepatitisOral antibioticsPrednisone therapyLivedo reticularisAutoimmune syndromeAutoimmune disordersCutaneous lesionsBiopsy specimensLower extremitiesHistologic examination